Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Details for Australian Patent Application No. 2008320875 (hide)

Owner Abbott GmbH & Co. KG

Inventors Lange, Udo; Haupt, Andreas; Bespalov, Anton; Jongen-Relo, Ana Lucia; Unger, Liliane; Turner, Sean Colm; Drescher, Karla; Braje, Wilfried

Agent Spruson & Ferguson

Pub. Number AU-A-2008320875

PCT Pub. Number WO2009/056600

Priority 07119788.3 31.10.07 EP

Filing date 30 October 2008

Wipo publication date 7 May 2009

International Classifications

C07D 213/76 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/444 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

21 January 2010 PCT application entered the National Phase

  PCT publication WO2009/056600 Priority application(s): WO2009/056600

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008320876-Method and apparatus for longitudinal orientation of thermoplastic film material

2008320874-Providing improved scheduling request signaling with ACK/NACK or CQI